Veratrak engaged with over 100 attendees and world class speakers to discuss the state of device packaging and labelling in Pharma.

Members from the Veratrak team were in the home of technology and innovation in November for the West Coast Pharma and Device Packaging and Labeling Conference, San Francisco. The team was excited to engage with over 100 attendees and world class speakers to discuss the state of device packaging and labelling in Pharma, both present and future. Topics ranged from solutions that optimize end-to-end artwork processes, to innovation as a means to resolve current real world industry issues. Hearing adjunct professor, Anthony D. Andre, address the human factors that need to be taken into account with the design of packaging and labelling was informative. "It was great to hear experts describe how they are tackling the need to optimize the packaging and artwork process. It is clear that there is a real appetite to address current efficiency issues in new and innovative ways. We strongly believe Veratrak provides a material piece in solving this issue through improved, secure document collaboration."— James Sully, Head of Partnerships James Sully at…

0 Comments

Jason Lacombe shared an overview of blockchain and discussed practical use cases for the technology at GIANT Health.

On Wednesday, October 16th, Veratrak’s Chief Executive Officer, Jason Lacombe, was invited to speak about Veratrak’s role in improving visibility, collaboration and data integrity across the pharmaceutical supply chain during the ‘Blockchain in Action’ session at GIANT Health 2019. The session was well attended with Jason first providing an overview of blockchain and then sharing practical use cases for the technology--subsequently sparking an interactive discussion. The audience agreed that the current processes for sharing documentation outside the walls of an organisation are not secure or collaborative, with the majority of information being exchanged over email. A few audience members shared stories of their own organisational impact from using unsecure channels of communication like email. Key takeaways from the session:Many organisations across the pharmaceutical supply chain are currently sharing batch documentation with their suppliers and partners through unsecure, non-collaborative and inefficient channels, with the majority using email.Using a modern SaaS platform, like Veratrak, and blockchain technology, allows for secure and compliant exchange of information outside the walls of an…

0 Comments

Jason Lacombe was invited to speak about Veratrak’s role in improving visibility, collaboration and data integrity across the pharmaceutical supply chain

On Thursday, October 24th, Veratrak’s Chief Executive Officer, Jason Lacombe, was invited to speak about how Veratrak is improving visibility, collaboration, and data integrity across the pharmaceutical supply chain; through working with a number of Contract Packaging Organisations (CPO’s) and their suppliers. The goal of the session was to explore how novel technologies like blockchain are being used by Veratrak customers to reduce lead times, free up working capital, and provide improved visibility and compliance of batch document collaboration processes. Jason first provided the audience with a practical overview of blockchain and then discussed a customer case study. Throughout the presentation, the audience shared their opinions on new technologies and how their organisations are beginning to explore digitisation. It was clear that organisations are currently sharing sensitive batch documentation using unsecure and non-collaborative channels, with the majority of information being exchanged over email. This has led to challenges with auditing suppliers, efficiently coordinating drug recalls, and in extreme cases, drug stock-outs. Key takeaways from the session:Many organisations across…

0 Comments

Veratrak team members engaged with over 410 exhibitors and 5500 attendees over two days in Paris.

Veratrak was in Paris on the 5th and 6th of February to attend the Pharmapack Europe 2020 conference. The conference welcomed a mix of contract packaging, manufacturing, development, and drug delivery organisations all showcasing their latest innovations. Jason Lacombe (CEO), Colin Tierney (Head of Product), and James Sully (Head of Partnerships) enjoyed catching up with clients and industry peers. Jason delivered a keynote talk centered around blockchain technology and its applicability towards security issues currently facing document collaboration processes between partners in the pharmaceutical supply chain. Jason Lacombe, CEO, Veratrak, delivers keynote speech The well-attended talk brought insightful questions from the audience around Public versus Private permissioned blockchains and how the Veratrak platform handled visibility into immutable audit trails. Thank you to the Pharmapack Europe team for executing another valuable conference and Veratrak looks forward to being back in 2021.

0 Comments

Veratrak Attends Pharma Packaging and Labeling East Coast 2020 Conference in Philadelphia

The Veratrak team travelled to Philadelphia in February to attend the Pharma Packaging and Labeling East Coast Conference. The team was excited to engage with the 150+ attendees and hear of the state of the art developments currently taking place in the US and Europe Pharma Packaging and Labeling environment. It was insightful for the team to understand how the market was tackling issues around serialisation, tracking and tracing of materials, and learn of new developments in making these processes more robust and efficient. On hearing Gerrit-Jan Nijveldt from Otsuka Pharmaceuticals address the audience about how using technology can help with CCDS: "It was interesting to hear Gerrit-Jan Nijveldt discuss how companies need to look at implementation of innovative technical solutions to create CCDS and downstream local labeling. As a solution based enterprise with innovation at our core, it was valuable to see how Veratrak can help address many of these pressing issues through improved, secure document collaboration."— James Sully, Head of Partnerships James Sully, Head of Partnerships,…

0 Comments

Veratrak’s Head of Product, Colin Tierney, discusses how innovative technology can break down data silos and increase transparency during Plug & Play’s Virtual Blockchain event

On June 17th, 2020, Veratrak’s Head of Product, Colin Tierney was invited to sit alongside other technology experts as a panel member to investigate the potential and challenges of blockchain in 2020. Colin was selected as the expert from the pharmaceutical and life sciences industry amongst a panel that included technology experts across multiple industries including energy, financial services, and food & agriculture. The COVID-19 crisis has caused major disruptions and revealed an opportunity for strengthening collaboration and data exchange in global supply chains. The pharmaceutical supply chain has been in need of a digital update prior to the pandemic and has recently revealed new opportunities where innovative, cloud-based platforms can tackle long-running issues related to unsecure exchange of critical documentation and inefficient processes. Colin shared how COVID-19 has affected the pharmaceutical industry’s adoption of technology, and specifically from the perspective of Veratrak, a rapid increase in use cases for digital auditing, electronic signatures of sensitive documents, and collaboration in the remote working era that Veratrak has helped…

0 Comments

Aoife Plunkett attended a session discussing the FDA’s Case for Quality, the challenges of CSV, and the requirement for critical thinking across all business departments and processes.

On 29th July 2020, Veratrak’s Quality Assurance Manager, Aoife Plunkett, attended a session on GAMP®5, FDA CSA, and the Future of Computer Systems Validation, hosted by ISPE. During this talk, industry experts discussed the FCD CDRH Case for Quality, and how GAMP® supports this focus on quality over compliance, by encouraging the use of innovative technologies, and the application of effective good practices. ISPE’s Specific Interest Groups (SIGs) were discussed. These SIGs are responsible for researching and publishing reports on new technologies, and include GAMP® Blockchain, GAMP® Cloud Computing and GAMP® Data Integrity, which tie in with our product at Veratrak and our process for developing new features. The final section of the discussion demonstrated how critical thinking, knowledge management, quality culture and maturity, and data governance are all essential for effective Computerised System Validation. Key takeaways from the webinar:Critical thinking and risk based approaches should be prioritised, rather than documentation and compliance.Increased investment in automation, and utilising cutting edge computerised tools, allows companies to proactively manage risks…

0 Comments

Veratrak CEO, Jason Lacombe, Discusses the Pharmaceutical and Biotechnology Supply Chain on the Molecule to Market Podcast with Host, Raman Sehgal

In Episode 20 (September 2020) of Molecule to Market, Jason touches on the importance of aiming for fewer stockouts, faster lead times, more secure documentation and most importantly, better patient outcomes. In Episode 20 (September 2020) of Molecule to Market, Jason touches on the importance of aiming for fewer stockouts, faster lead times, more secure documentation and most importantly, better patient outcomes. In this episode of Molecule to Market, Jason and Raman go inside the outsourcing space of the global drug development sector and dive into long-standing problems that Veratrak is tackling throughout the supply chain. Raman discusses the impact Covid-19 has had on accelerating the digitisation of the global pharmaceutical supply chain, and Jason speaks about dealing with inertia and how it is now more clear than ever; the old way of doing things is not fit for our modern world. Lastly, Jason touches on the importance of aiming for fewer stockouts, faster leader times, more secure documentation and most importantly, better patient outcomes. The episode, From Fax…

0 Comments

Remote Auditing: How can the life sciences supply chain adapt?

Business operations in many industries have had to adapt to restrictions in place to curb the spread of Covid-19. While some operations can be paused until it is safe to resume normal practices, like working alongside colleagues or in-person trade shows, for many of the world’s critical industries, customers and suppliers must carry on communicating and collaborating. GxP manufacturing in the pharmaceutical industry has had to adjust to meet the challenges Covid-19 poses. The pharmaceutical supply chain, continuing to develop, test, manufacture, and ship medicine across borders around the world, has to ensure rigorous quality for these processes now, more than ever. To ensure this quality is achieved, supplier audits are performed both when on-boarding a new supplier and then periodically to track continued quality over time. These audits traditionally take place in-person, with customers visiting their suppliers (often across continents) to view manufacturing operations and review quality documentation, certificates, and process documents. With ongoing travel restrictions, pharmaceutical companies have had to quickly pivot to carrying out remote…

0 Comments